A rapid method for analyzing serum pro-insulin-like growth factor-II in patients with non-islet cell tumor hypoglycemia.
The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Abstract
CONTEXT: Non-islet cell tumor hypoglycemia (NICTH) results from the hypersecretion of pro-IGF-II by a large, usually mesenchymal tumor. Detection of pro-IGF-II in serum is a potential tumor marker in these patients. OBJECTIVE: The aim of this study was to validate a rapid and reliable method for determining serum pro-IGF-II. PATIENTS: Serum samples from 16 patients with NICTH were studied. MAIN OUTCOME MEASURE: The main outcome measure was serum concentration of pro-IGF-II determined by immunoblot analysis of pro-IGF-II and mature IGF-II after 16.5% tricine-SDS-PAGE, which was compared with pro-IGF-II measured by standard RIA after size-exclusion acid chromatography. RESULTS: The analyses of patients' sera by size-exclusion acid chromatography showed that 68 +/- 19% of IGF-II were present in the pro-IGF-II form, whereas only 18 +/- 4% corresponded to pro-IGF-II in controls. Scanning densitometry of immunoblots showed 67 +/- 16% in the bands corresponding to pro-IGF-II in patients' sera, compared with 27 +/- 9% in controls. The detection sensitivity of tricine-SDS-PAGE method was the same as for size-exclusion chromatography, but the tricine-SDS-PAGE method is quicker and requires smaller amounts of serum. CONCLUSION: Tricine-SDS-PAGE followed by IGF-II immunoblot analysis provides a rapid, reproducible, and sensitive method for the separation of serum pro-IGF-II from mature IGF-II and is a useful laboratory evaluation of patients with a clinical diagnosis of NICTH.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The total level of IGF-II may be normal, but the ratio of pro-IGF-II to IGF-II may be elevated; this can be demonstrated by chromatographic techniques, most easily and rapidly using thin layer chromatography (29).”
From Evaluation and Management of Adult Hypoglycemic Disorders: An Endocrine Society Clinical Practice Guideline (2009) · cites this paper as [29]
Citations
Cites
Schägger, H., & von Jagow, G. (1987) · Analytical Biochemistry · doi:10.1016/0003-2697(87)90587-2 · Cited by 11,444
Comparing methods of measurement: why plotting difference against standard method is misleading
Bland, J. M., & Altman, D. G. (1995) · The Lancet · doi:10.1016/s0140-6736(95)91748-9 · Cited by 2,343
Insulin-like growth factors I and II in healthy man.
Guler, H.-P., Zapf, J., Schmid, C., & Froesch, E. R. (1989) · Acta Endocrinologica · doi:10.1530/acta.0.1210753 · Cited by 531
Daughaday, W. H., Emanuele, M. A., Brooks, M. H., Barbato, A. L., Kapadia, M., & Rotwein, P. (1988) · New England Journal of Medicine · doi:10.1056/nejm198812013192202 · Cited by 351
Sequence of a cDNA clone encoding human preproinsulin-like growth factor II
Bell, G. I., Merryweather, J. P., Sanchez-Pescador, R., Stempien, M. M., Priestley, L., Scott, J., & Rall, L. B. (1984) · Nature · doi:10.1038/310775a0 · Cited by 321
Sleep apnoea and nocturnal angina
Franklin, K. A., Sahlin, C., Nilsson, J. B., & Näslund, U. (1995) · The Lancet · doi:10.1016/s0140-6736(95)90820-x · Cited by 308
Zapf, J., Futo, E., Peter, M., & Froesch, E. R. (1992) · Journal of Clinical Investigation · doi:10.1172/jci116152 · Cited by 172
Davenport, M. L., CLEMMONS, D. R., Miles, M. V., Camacho‐Hübner, C., D’ERCOLE, A. J., & UNDERWOOD, L. E. (1990) · Endocrinology · doi:10.1210/endo-127-3-1278 · Cited by 154
Daughaday, W. H., & Kapadia, M. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.17.6778 · Cited by 136
Baxter, R. C. (1995) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.80.9.2700 · Cited by 127
Post-translational Processing of the Insulin-like Growth Factor-2 Precursor
Duguay, S. J., Jin, Y., Stein, J., Duguay, A. N., Gardner, P., & Steiner, D. F. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.29.18443 · Cited by 118
Bowsher, R. R., Lee, W., APATHY, J. M., O'Brien, P. J., Ferguson, A. L., & Henry, D. P. (1991) · Endocrinology · doi:10.1210/endo-128-2-805 · Cited by 118
BAXTER, R. C., & DAUGHADAY, W. H. (1991) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-73-4-696 · Cited by 103
Daughaday, W. H., Trivedi, B., & Baxter, R. C. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.12.5823 · Cited by 97
RON, D., POWERS, A. C., PANDIAN, M. R., GODINE, J. E., & AXELROD, L. (1989) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-68-4-701 · Cited by 77
Morrell, D. J., Dadi, H., More, J., Taylor, A. M., Dabestani, A., Buchanan, C. R., Holder, A. T., & Preece, M. A. (1989) · Journal of Molecular Endocrinology · doi:10.1677/jme.0.0020201 · Cited by 62
The Role of Insulin-Like Growth Factors and Their Binding Proteins in Tumor Hypoglycemia
Baxter, R. C. (1996) · Hormone Research · doi:10.1159/000185023 · Cited by 58
Daughaday, W. H. (1992) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.75.1.110 · Cited by 57
Bond, J., Meka, S., & Baxter, R. (2000) · Journal of Endocrinology · doi:10.1677/joe.0.1650253 · Cited by 52
Insulinlike growth factor binding proteins and tumor hypoglycemia
Zapf, J. (1995) · Trends in Endocrinology and Metabolism · doi:10.1016/1043-2760(94)00144-s · Cited by 47
The identification of O-glycosylated precursors of insulin-like growth factor II.
Hudgins, W. R., Hampton, B., Burgess, W. H., & Perdue, J. F. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)42420-9 · Cited by 43
Boulle, N. (2000) · Endocrinology · doi:10.1210/en.141.9.3127 · Cited by 39
Khosla, S. (2002) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.87.8.3867 · Cited by 35
Cotterill, A. M., Holly, J. M. P., Davies, S. C., Coulson, V. J., Price, P. A., & Wass, J. A. H. (1991) · Journal of Endocrinology · doi:10.1677/joe.0.1310303 · Cited by 33
Liu, F., Baker, B. K., Powell, D. R., & Hintz, R. L. (1993) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.76.5.8496298 · Cited by 25
Christofilis, M., Remacle-Bonnet, M. M., Atlan-Gepner, C., Garrouste, F. L., Vialettes, B., Fuentes, P., Guidicelli, R., & Pommier, G. J. (1998) · European Journal of Endocrinology · doi:10.1530/eje.0.1390317 · Cited by 13
Non-islet-cell tumour induced hypoglycaemia: a case report and review of literature
Kuenen, B. C., VANDOORN, J., & Slee, P. (1996) · The Netherlands Journal of Medicine · doi:10.1016/0300-2977(95)00073-9 · Cited by 11
Cited by
Clinical Practice Guidelines for Multiple Endocrine Neoplasia Type 1 (MEN1)
Thakker, R. V., Newey, P. J., Walls, G. V., Bilezikian, J., Dralle, H., Ebeling, P. R., Melmed, S., Sakurai, A., Tonelli, F., & Brandi, M. L. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-1230 · Cited by 1,477
Francis, G. L., Waguespack, S. G., Bauer, A. J., Angelos, P., Benvenga, S., Cerutti, J. M., Dinauer, C. A., Hamilton, J., Hay, I. D., Luster, M., et al. (2015) · Thyroid · doi:10.1089/thy.2014.0460 · Cited by 1,238
Cryer, P. E., Axelrod, L., Grossman, A. B., Heller, S. R., Montori, V. M., Seaquist, E. R., & Service, F. J. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1410 · Cited by 1,277
Self-citationDynkevich, Y., Rother, K. I., Whitford, I., Qureshi, S., Galiveeti, S., Szulc, A. L., Danoff, A., Breen, T. L., Kaviani, N., Shanik, M. H., et al. (2013) · Endocrine Reviews · doi:10.1210/er.2012-1033 · Cited by 224
“Most recently, a more rapid assay has been developed that employs thin layer chromatography (109).”
MethodManagement of Non-Islet-Cell Tumor Hypoglycemia: A Clinical Review
Bodnar, T. W., Acevedo, M. J., & Pietropaolo, M. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-3382 · Cited by 217
“raki-Moud et al (15) published 16 cases.”
MethodInfluential
Metadata
- Authors
- Miraki-Moud, F., Grossman, A. B., Besser, M., Monson, J. P., & Camacho-Hübner, C.
- Affiliations
- Department of Endocrinology, William Harvey Research Institute, Queen Mary University of London, London EC1M 6BQ, United Kingdom
- Queen Mary University of London (GB)
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2005-07-01
- Volume
- 90
- Issue
- 7
- Pages
- 3819-3823
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2171902529
- Semantic Scholar
- 04edda76952c221cd45d81153f532322c681cfa0
- Cited by
- 44
- References
- 27
- Citations by year
- 2024: 3 · 2023: 3 · 2022: 1 · 2021: 2 · 2020: 4 · 2019: 2 · 2018: 2 · 2017: 1 · 2016: 3 · 2015: 1 · 2014: 2 · 2013: 3 · 2012: 2
- FWCI
- 1.64
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Pfizer
- National Institute on Alcohol Abuse and Alcoholism (R37AA011408)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Growth Hormone and Insulin-like Growth Factors
- Health Sciences › Medicine › Oncology › Neuroendocrine Tumor Research Advances
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Keywords
- non-islet cell tumor hypoglycemia, insulin-like growth factor II, Tricine-SDS-PAGE, immunoblot analysis, size exclusion chromatography, tumor markers, mesenchymal tumors, hypoglycemia
- MeSH terms
- Adult, Aged, Aged, 80 and over, Chromatography, Gel, Female, Humans, Hypoglycemia, Insulin-Like Growth Factor I, Insulin-Like Growth Factor II, Male, Middle Aged, Neoplasms, Protein Precursors, Blotting, Western
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.